Bronchiolitis guidelines: what about the Italian situation in a primary care setting?

Table 1 International guidelines on bronchiolitis: focus on recommendations about inhaler β2-agonists, systemic steroids and antibiotics use

	South Africa 2010 [10]	Spain 2010 [9]	France 2013 [3]	AAP (USA) 2014 [7]	CPS (Canada) 2014 [8]	NICE (UK) 2015 [4]	Australia NZ 2019 [6]	Italy 2022 [5]
Child’s age	< 24 m	< 24 m	< 12 m	1–23 m	< 24 m	n.s.	< 12 m	< 12 m
β2-agonists	n.r.*	n.r.	n.r.°	n.r.	n.r.	n.r.	n.r.	n.r.
Steroids	n.r.	n.r.	n.r.	n.r.	n.r.	n.r.	n.r.	n.r.
Antibiotics	n.s.	n.r.•	n.r.•	n.r.•	n.r.•	n.r.	n.r.	n.r.•

Legend: m; months; n.s., not specified; n.r., not recommended
* Trials with β2-agonists can be considered in hypoxic infants
° Trial with β2-agonists can be considered in child with recurrent wheeze, atopic history, and not clear clinical features
• Antibiotic use is allowed in presence of documented secondary bacterial infection

ISSN: 1824-7288